54th Annual Meeting of The American Association for the Study of Liver Diseases
October 24 - 28, Boston, Massachusetts USA
Page 1 of 1
PHASE III, PARTIALLY DOUBLE-BLINDED STUDY EVALUATING THE EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2......
EPIDEMIOLOGICAL DATA OF HEPATITIS B INFECTION IN FRANCE: RESULTS OF NATIONWIDE SURVEY
LONG TERM FOLLOW UP OF SUSTAINED RESPONDERS TO INTERFERON ALPHA IN CHRONIC HEPATITIS C: A META-ANALY......
HCV PRESENCE IN GENITAL SECRETIONS IN HIV/HCV COINFECTED WOMEN
SEXUAL TRANSMISSION OF HEPATITIS C VIRUS IN HETEROSEXUAL MONOGAMOUS COUPLES - THE HCV PARTNERS STUDY......
Weight-based Dosing of PEG-Intron or Double the Dose Plus Ribavirin for Naïve Patients and Double Do......
SHORT TREATMENT (14 WEEKS) WITH PEGYLATED INTERFERON ALPHA-2B AND RIBAVIRIN FOR THE TREATMENT OF HEP......
Patients with High HCV Viral Load, Genotype 1 and Cirrhosis May Require More Than 48 Weeks Combinati......
Pharmacokinetics of Pegasys Compared to PEG-Intron in Treatment-Naïve Patients with Chronic Hepatiti......
TREATMENT OF CHRONIC HEPATITIS B/C COINFECTED PATIENTS WITH CONSENSUS INTERFERON / RIBAVIRIN / LAMIV......
LONG TERM FOLLOW-UP OF GLYCYRRHIZIN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND NON-RESPONSE TO......
CHRONIC HEPATITIC C VIRUS INFECTION AND INSULIN RESISTANCE: HOW DO THEY INTERACT, AND WHAT IS THE EF......
CITALOPRAM FOR PREVENTION OF INTERFERON-ALPHA ASSOCIATED DEPRESSION IN PSYCHIATRIC RISK PATIENTS
A NATIONAL, MULTICENTER STUDY OF HIGH-DOSE PEGINTERFERON ALFA-2B + RIBAVIRIN FOR NON-RESPONDERS WITH......
SAFETY AND ANTIVIRAL EFFECT OF BILN 2061, A NOVEL HCV SERINE PROTEASE INHIBITOR
The Liver Meeting
Go to page 1
<< Index